Emerging evidence implies that AMPK activation in tumor cells engenders the ubiquitination and degradation of HIF-1α, thereby counteracting its activation (Seo et al., 2016; Wang et al., 2022a; Chen et al., 2022). Here, PRKAA1 is linked to neoplasm.